STADA Arzneimittel AG — Earnings Release 2013

Mar 3, 2014

News Details

Ad-hoc | 3 March 2014 13:55

STADA Arzneimittel AG: Preliminary figures show successful financial year 2013 – Dividend to increase by 32 percent – Outlook for 2014 confirmed

STADA Arzneimittel AG / Key word(s): Miscellaneous

03.03.2014 13:55

Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted
by DGAP - a company of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

---

Bad Vilbel, March 3, 2014 - On the basis of the preliminary figures for
financial year 2013, today March 3, 2014, the Executive Board of STADA
Arzneimittel AG has taken a resolution on the dividend proposal for the
past financial year. According to the proposal, the STADA Executive Board
recommends that the Supervisory Board propose to the next Annual General
Meeting on June 4, 2014 a dividend for financial year 2013 in the amount of
Euro 0.66 per common share (previous year: Euro 0.50). This would represent
an increase in dividend of 32 percent as compared to the previous year. The
Executive Board also confirmed the forecast for financial year 2014 as
given in 2010.

According to preliminary Group key figures, Group sales in 2013 are
expected to have increased by 10 percent to Euro 2,014.4 million and
thereby amount to over two billion euros for the first time. All reported
and adjusted key earnings figures at the Group level are anticipated to
show growth. Reported EBITDA, thereby, is expected to have increased by 18
percent to Euro 383.5 million. EBITDA adjusted for one-time special effects
is estimated to have risen by 13 percent to Euro 415.2 million and thereby
reached a new record high in corporate history. Reported net income
recorded growth of an anticipated 40 percent to Euro 121.4 million. Net
income adjusted for one-time special effects and effects from the
measurement of derivative financial instruments within financial income and
expenses is expected to have risen by 9 percent to Euro 160.6 million.
Reported earnings per share are anticipated to have increased to Euro 2.04
(previous year: Euro 1.46). Earnings per share adjusted for one-time
special effects and effects from the measurement of derivative financial
instruments within financial income and expenses rose to an anticipated
Euro 2.70 (previous year: Euro 2.50).

As of the balance sheet date, net debt is expected to come to Euro 1.306.8
million (December 31, 2012: Euro 1,177.3 million). As of December 31, 2013,
the net debt to adjusted EBITDA ratio is expected to amount to 3.1
(previous year: 3.2).

For the outlook, the Executive Board expects further growth and confirms
the prognosis for financial year 2014 as given in 2010. According to this,
Group sales of Euro 2.15 billion, adjusted EBITDA of Euro 430 million and
adjusted net income of Euro 215 million could be reached.

STADA will publish its final figures for financial year 2013 on March 27,
2014.

STADA key figures at a glance

                      2013 (approx.         2012               +/-
                      figures)

Group sales EUR 2,014.4 million EUR 1,837.5 +10%
million

EBITDA EUR 383.5 million EUR 323.7 million +18%

EBITDA, adjusted EUR 415.2 million EUR 367.4 million +13%

Net income EUR 121.4 million EUR 86.5 million +40%

Net income, adjusted EUR 160.6 million EUR 147.9 million +9%

Earnings per share EUR 2.04 EUR 1.46 +40%

Earnings per share, EUR 2.70 EUR 2.50 +8%
adjusted

Additional information:
STADA Arzneimittel AG / Corporate Communications / Stadastraße 2-18 / 61118
Bad Vilbel - Germany / Phone: +49 (0) 6101 603-113 / Fax: +49 (0) 6101
603-506 / e-mail: communications@stada.de
Or visit us in the Internet at www.stada.com.

03.03.2014 DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---

Language: English
Company: STADA Arzneimittel AG
Stadastraße 2-18
61118 Bad Vilbel
Germany
Phone: +49 (0)6101 603- 113
Fax: +49 (0)6101 603- 506
E-mail: communications@stada.de
Internet: www.stada.de
ISIN: DE0007251803, DE0007251845,
WKN: 725180, 725184,
Indices: MDAX
Listed: Regulierter Markt in Düsseldorf, Frankfurt (Prime Standard);
Freiverkehr in Berlin, Hamburg, Hannover, München, Stuttgart

End of Announcement DGAP News-Service

---